Brilliant Blue-G (BBG), a non-competitive antagonist of the P2X7 receptor, showed its biological activity by reverting loss of dopaminergic neurons in an animal model of Parkinson’s disease [83] and blocking P2X7 receptor-promoted tumor engraftment and metastasis [6]. Here, P2RX7 is linked to neoplasm.